Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
NeuroVia is a biopharmaceutical company.
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Novartis has invested in 99 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Biotechnology, Therapeutics, Biopharma, Medical, Health Care. The firm invests across 7 different industry categories.
Among tracked funding rounds, Raze Therapeutics received $24.0M in a Series A round. Novartis's total known invested capital is $3.8B.
Novartis's average investment size is $60.5M across its portfolio of 99 companies.